Introduction. The epidemiology of benign diseases of breast is studied less than breast cancer epidemiology. This circumstance could be explained by the absence of the regular records and statistical analysis of benign diseases of breast. Thus the data about the incidence of these diseases could be obtained only by the special population surveys.
Goal and objectives. The study was aimed to develop and assess the effectiveness of decision making directed to the improvement of the indices of screening benign diseases of breast and early stages of breast cancer.
Materials and methods. The retrospective study was conducted by the analysis of the medical reports for 2009–2012. The statistical analysis of obtained data was conducted by the methods of frequency analysis with the use c2 non-parametric criterion. The differences were assessed as statistically significant for p<0.05.
Results. There was developed the complex of the measures containing the infrastructure development directed to decrease the incidence and mortality due to breast cancer
Conclusion. The amount of diagnosed cases of benign breast displasia (ICD-X code N60–64) was increased by 12.8% after the system of monitoring was introduced in 2011. This index was leveled in 2012 and the quantity of diagnosed cases of benign breast tumours (ICD-X code D24) increases by 12.0% in 2012. Simultaneously there was increased the index of detecting early stages of breast cancers during the preventive health surveys.